Ohmx Funding: How Much Did They Raise & Key Investors

How Much Did Ohmx Raise?
Funding & Key Investors

Ohmx, an Evanston-based innovator in the clinical diagnostics sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $3M. This latest infusion of $3M underscores the market confidence in the company's proprietary bioelectronic platform, which aims to redefine the landscape of point-of-care (POC) testing. By prioritizing accuracy and cost-efficiency, Ohmx is positioning itself as a critical player in the transition toward decentralized medical diagnostics.

The recent financing round serves as a pivotal milestone for the organization, providing the necessary runway to accelerate the development of its comprehensive testing menu. As the healthcare industry shifts toward rapid, actionable data, Ohmx's ability to quantify proteins, small molecules, and DNA from low-volume biological samples offers a distinct competitive advantage in both acute and chronic disease management.

What is Ohmx?

Ohmx

Business Services

Research & Development

Manufacturing

Ohmx operates at the intersection of biotechnology and clinical diagnostics, focusing on the development of a versatile POC system designed to streamline patient care. The company's core technology is a bioelectronic platform capable of delivering high-fidelity analyses that were previously confined to centralized laboratory settings. Its flagship product, a C-Reactive Protein (CRP) test, exemplifies this mission by enabling clinicians to differentiate between viral and bacterial inflammation, thereby optimizing antibiotic stewardship. Furthermore, the platform's capacity to measure hsCRP for cardiovascular risk stratification highlights its utility in preventative medicine. By integrating these diagnostic capabilities directly into the physician's workflow, Ohmx not only enhances clinical decision-making but also provides a sustainable revenue model for medical practices, effectively bridging the gap between laboratory precision and bedside convenience.

How much funding has Ohmx raised?

Ohmx has raised a total of $3M across 1 funding round:

2017

Debt

$3M

Debt (2017): $3M, investors not publicly disclosed

Key Investors in Ohmx

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Ohmx?

With the successful closure of this major enterprise-level funding, Ohmx is poised to scale its operational capabilities and expand its assay portfolio. The strategic roadmap likely involves intensifying clinical validation efforts and navigating the regulatory pathways required for a broader market rollout. As the company transitions from a development-focused entity to a commercial-stage enterprise, the focus will shift toward manufacturing scalability and establishing strategic partnerships with healthcare providers. The long-term objective remains the democratization of diagnostic testing, ensuring that high-quality, actionable health data is accessible at the point of care, ultimately driving better patient outcomes and reducing the systemic burden on traditional laboratory infrastructure.

See full Ohmx company page

See More Financial Insights